| RS2114737043 |
ENPP1
|
Health Risk |
Pathogenic |
Arterial calcification, generalized |
| RS2114740915 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114757071 |
MED23
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 18 |
| RS2114761115 |
LAMA2
|
Health Risk |
Likely pathogenic |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2114765432 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114765447 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114765686 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114770006 |
LAMA2
|
Health Risk |
Likely pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114774712 |
LAMA2
|
Health Risk |
Pathogenic |
— |
| RS2114774731 |
LAMA2
|
Health Risk |
Pathogenic |
— |
| RS2114788484 |
LAMA2
|
Health Risk |
Likely pathogenic |
Abnormality of the musculature, LAMA2-related muscular dystrophy |
| RS2114788785 |
LAMA2
|
Health Risk |
Likely pathogenic |
Abnormality of the musculature, Abnormality of the musculature |
| RS2114788848 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114793034 |
HACE1
|
Health Risk |
Likely pathogenic |
Spastic paraplegia-severe developmental delay-epilepsy syndrome, Spastic paraplegia-severe developmental delay-epilepsy syndrome |
| RS2114794775 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2114795375 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS2114795567 |
LAMA2
|
Health Risk |
Pathogenic |
— |
| RS2114801377 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114823738 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114823800 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114834489 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS2114834541 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114834553 |
LAMA2
|
Health Risk |
Likely pathogenic |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS2114834693 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114839550 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114839785 |
HACE1
|
Health Risk |
Pathogenic |
— |
| RS2114848887 |
LAMA2
|
Health Risk |
Pathogenic |
Merosin deficient congenital muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2114848989 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114849006 |
LAMA2
|
Health Risk |
Pathogenic |
— |
| RS2114849148 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2114859541 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114859580 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114859967 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2114860862 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114873123 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114873389 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114883576 |
TAB2
|
Health Risk |
Pathogenic |
Congenital heart defects, multiple types |
| RS2114884577 |
TAB2
|
Health Risk |
Pathogenic |
— |
| RS2114885325 |
TAB2
|
Health Risk |
Likely pathogenic |
Congenital heart defects, multiple types |
| RS2114885719 |
TAB2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2114886711 |
TAB2
|
Health Risk |
Likely pathogenic |
Congenital heart defects, multiple types |
| RS2114887873 |
TAB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital heart defects, multiple types |
| RS2114887942 |
TAB2
|
Health Risk |
Pathogenic |
Primary dilated cardiomyopathy, Congenital heart defects |
| RS2114888164 |
TAB2
|
Health Risk |
Pathogenic |
— |
| RS2114888603 |
LAMA2
|
Health Risk |
Pathogenic |
— |
| RS2114888851 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114890695 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114890769 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114890786 |
LAMA2
|
Health Risk |
Pathogenic |
Merosin deficient congenital muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2114891707 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114900265 |
LAMA2
|
Health Risk |
Pathogenic |
— |
| RS2114900655 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2114900886 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114901040 |
LAMA2
|
Health Risk |
Likely pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114901162 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114910650 |
LAMA2
|
Health Risk |
Pathogenic |
Merosin deficient congenital muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2114911219 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114931095 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114931240 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114938789 |
RMND1
|
Health Risk |
Pathogenic |
— |
| RS2114939208 |
LAMA2
|
Health Risk |
Pathogenic |
Abnormality of the musculature, Abnormality of the musculature |
| RS2114939704 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114939796 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114939909 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114939917 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114941534 |
TAB2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2114941976 |
TAB2
|
Health Risk |
Pathogenic |
— |
| RS2114943862 |
MPC1
|
Health Risk |
Likely pathogenic |
Mitochondrial pyruvate carrier deficiency, Mitochondrial pyruvate carrier deficiency |
| RS2114947621 |
LAMA2
|
Health Risk |
Likely pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114957290 |
DLL1
|
Health Risk |
Pathogenic |
— |
| RS2114958184 |
DLL1
|
Health Risk |
Pathogenic |
— |
| RS2114958269 |
DLL1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures, Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures |
| RS2114958680 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114958704 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114964219 |
LAMA2
|
Health Risk |
Pathogenic |
Merosin deficient congenital muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2114964292 |
DLL1
|
Health Risk |
Pathogenic |
— |
| RS2114964680 |
DLL1
|
Health Risk |
Pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2114966765 |
DLL1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures, Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures |
| RS2114967780 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114967814 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2114967843 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114969441 |
PLN
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1P, Dilated cardiomyopathy 1P |
| RS2114970035 |
PLN
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1P, Dilated cardiomyopathy 1P |
| RS2114976490 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114993311 |
LAMA2
|
Health Risk |
Pathogenic |
Merosin deficient congenital muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2114993363 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114999450 |
ARID1B
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2114999746 |
ARID1B
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS2115000174 |
ARID1B
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS2115002258 |
ARID1B
|
Health Risk |
Likely pathogenic |
Congenital cerebellar hypoplasia, Corpus callosum |
| RS2115003519 |
ARID1B
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2115003731 |
ARID1B
|
Health Risk |
Pathogenic |
— |
| RS2115028353 |
PNLDC1
|
Health Risk |
Pathogenic |
Male infertility with azoospermia or oligozoospermia due to single gene mutation, Spermatogenic failure 57 |
| RS2115031969 |
ADGRG6
|
Health Risk |
Pathogenic |
Lethal congenital contracture syndrome 9, Lethal congenital contracture syndrome 9 |
| RS2115032171 |
REV3L
|
Health Risk |
Pathogenic |
— |
| RS2115034640 |
FAM20C
|
Health Risk |
Pathogenic |
— |
| RS2115035271 |
CARD11
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to CARD11 deficiency, BENTA disease |
| RS2115037261 |
LAMA2
|
Health Risk |
Likely pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2115038523 |
CARD11
|
Health Risk |
Likely pathogenic |
Immunodeficiency 11b with atopic dermatitis, Immunodeficiency 11b with atopic dermatitis |
| RS2115044716 |
CARD11
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to CARD11 deficiency, BENTA disease |